[144] Cencora, Inc. SEC Filing
Rhea-AI Filing Summary
Cencora, Inc. (COR) Form 144 shows proposed and recent insider sales of common stock by Steven Collis. The filing notifies a brokered proposed sale of 14,579 shares with an aggregate market value of $4,227,618.42 scheduled for 08/19/2025 on the NYSE through Fidelity Brokerage Services. The filing also discloses the acquisition history for the shares to be sold: 2,000 shares from restricted stock vesting on 09/30/2023 (compensation) and 12,579 shares from an option exercise dated 08/19/2025 (cash).
Separately, three insider sales by Steven Collis during the past three months are reported: 14,578 shares on 05/20/2025 for $4,283,599.52, 14,579 shares on 06/24/2025 for $4,266,106.98, and 14,578 shares on 07/22/2025 for $4,265,100.54. The filing includes the seller's representation about lack of undisclosed material information and a signature notice regarding legal penalties for misstatement.
Positive
- Form 144 filed and detailed: The notice identifies broker, share counts, acquisition dates, and aggregate values, meeting Rule 144 disclosure requirements.
- Acquisition sources disclosed: The filing specifies that shares arose from restricted stock vesting and an option exercise, clarifying the nature of holdings being sold.
Negative
- Repeated insider dispositions: Three recent sales totaling 43,735 shares generated approximately $12,814,807.04 in gross proceeds, with an additional proposed sale of 14,579 shares (~$4,227,618.42).
- No 10b5-1 plan date disclosed: The filing lists dates for plan adoption/instruction fields but provides no plan adoption date, so it does not evidence a pre-arranged trading plan in the notice.
Insights
TL;DR: Multiple, regular insider sales totaling about $12.8M recently, plus a proposed sale of ~14.6k shares (~$4.23M).
The disclosed transactions indicate a sequence of sizeable dispositions by the same insider over several months: three executed sales in May, June and July 2025 each around 14.5k shares generating roughly $4.26M each, totaling approximately $12,814,807.04. The scheduled sale on 08/19/2025 would add another 14,579 shares and about $4.23M in market value. From a financial perspective, these are material amounts in absolute dollar terms and represent recurring liquidity events from one individual. The Form 144 provides clear mechanics (broker, share counts, acquisition dates) but contains no explanation of intent beyond standard representations.
TL;DR: Repeated insider sales are documented and properly disclosed, raising governance questions but not proving impropriety.
The filing meets Rule 144 disclosure mechanics by identifying the broker, share counts, acquisition sources (restricted stock vesting and option exercise), and recent sales. Recurrent sales by the same named individual may prompt investor scrutiny about insider alignment with shareholders, yet the form itself contains no allegation of nondisclosure or breach. The signer makes the required representation about absence of undisclosed material information. Without additional context (e.g., pre-arranged trading plan language or company policy), the disclosure is compliant but notable for frequency and scale.